Great efforts are being made to find new treatments for people with inflammatory bowel disease (IBD), specifically the two main forms of IBD: Crohn’s disease and ulcerative colitis. This research to find better, safer, more effective treatments is encouraging because despite all of the treatments available (e.g. Humira, Entyvio, Budesonide, Stelara, etc.), many people with IBD are still not in remission and do not experience a great quality of life.
The images below list out many of the emerging treatments (i.e. treatments only accessible through clinical trials) available for Crohn's disease and ulcerative colitis that researchers and patients are excited about.
Each of the emerging treatments listed above is being evaluated in a clinical trial. Many trials happen at hundreds of clinics around the world, giving patients access to these emerging treatments through local Crohn’s and colitis specialists. By following the links below, you can see if you qualify for a particular trial. If you do, then that treatment may give you one more option to get your Crohn’s disease or ulcerative colitis under control.
Adalimumab vs Ustekinumab for Crohn’s
Etrolizumab for Crohn’s and ulcerative colitis
Guselkumab for Crohn’s
Guselkumab for ulcerative colitis
JNJ-64304500 for Crohn’s
Mirikizumab for ulcerative colitis
QBECO SSI for Crohn’s
Filgotinib for Crohn's and ulcerative colitis
IMU-838 for ulcerative colitis
BMS-986165 for Crohn's
SER-287 for ulcerative colitis
It takes years before emerging treatments like these are widely available. The only way to get early access to them is through a clinical trial. Clinical trials provide patients with valuable access to new IBD treatments however not all trials are available to everyone. Learn the important considerations regarding timing in order to keep your options for clinical trials open.
We hope this information is helpful to you as you explore options for treating your IBD. Our team at Discover Therapies believes when people have the right information, they are empowered to make better decisions with their doctors, ultimately leading to better outcomes.
In case it is of help to you, here is a list of IBD experts across North America that have special access to emerging treatments.
Thank you to Claire at Robarts Clinical Trials for helping curate the list of active trials!